Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $81.81 USD
Change Today 0.00 / 0.00%
Volume 2.1M
LLY On Other Exchanges
SIX Swiss Ex
Sao Paulo
As of 1:58 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael T. Heffernan B.S. Pharm, R.Ph.

AgeTotal Calculated CompensationThis person is connected to 54 board members in 6 different organizations across 8 different industries.

See Board Relationships


Mr. Michael T. Heffernan, also known as Mike, RPh, B.S. Pharm., Co-founded Collegium Pharmaceutical, Inc. in 2002 and has been its Chief Executive Officer & President since 2002. Mr. Heffernan has been Senior Medical Advisor to Advocacy and Medical Education Efforts at Eli Lilly and Company since January 2013. He served as the Chief Executive Officer and President at Clinical Studies Ltd. (CSL) from 1995 to 1999. He is a Proven Entrepreneur and Senior Level Executive ...

Read Full Background

Corporate Headquarters*

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: --

Board Members Memberships*

Founder, Chief Executive Officer, President, Treasurer, Secretary, Director and Member of Nominating & Corporate Governance Committee
Chairman of the Board
Director and Member of Compensation Committee
Director, Chairman of Compensation Committee, Member of Investment Committee and Member of Special Committee
Chairman, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee


University of Connecticut

Other Affiliations*

Annual Compensation*

Total Annual Compensation$380,380

Stock Options*

All Other Compensation$7,570
Exercisable Options319,250
Exercisable Options Value$219,075
Unexercisable Options50,000
Unexercisable Options Value$40,500
Total Value of Options$259,575
Total Number of Options369,250

Total Compensation*

Total Annual Cash Compensation$518,801
Total Short Term Compensation$380,380
Other Long Term Compensation$7,570
Total Calculated Compensation$518,801
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $81.81 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at